Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins

Neurology

Volumn 80, Issue 2, 2013, Pages 145-151

  Gaitán, María I ^a   De Alwis, Manori P ^a,b   Sati, Pascal ^a   Nair, Govind ^a   Reich, Daniel S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; ARTICLE; BRAIN VEIN; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; VEIN DIAMETER; WHITE MATTER;

ADULT; CEREBRAL VEINS; CONTRAST MEDIA; DISABILITY EVALUATION; FEMALE; GADOLINIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEX CHARACTERISTICS;

EID: 84873638442     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827b916f     Document Type: Article

References (32)

1. Charcot JM. Histologie de la Sclérose en Plaques. Paris: Imprimerie L. Pupart-Davyl; 1869.
2. Adams CW. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci 1975;25:165-182.
3. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-717. (Pubitemid 30390191)
4. Mohan H, Krumbholz M, Sharma R, et al. Extracellular matrix in multiple sclerosis lesions: fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol 2010;20:966-975.
5. Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venog-raphy of multiple sclerosis. AJNR Am J Neuroradiol 2000; 21:1039-1042.
6. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076-2078.
7. Ge Y, Zohrabian VM, Osa EO, et al. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 2009;29:1190-1194.
8. Tallantyre EC, Morgan PS, Dixon JE, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009;44:491-494.
9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452. (Pubitemid 14237132)
10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
11. Fog T. On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand Suppl 1964;40 (suppl 10):9-15.
12. Dawson JW. The histology of disseminated sclerosis. Trans Roy Soc Edin 1916;50:74-75.
13. Adams CW, Poston RN, Buk SJ, Sidhu YS, Vipond H. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 1985;69:269-283. (Pubitemid 15074622)
14. Gareau PJ, Wymore AC, Cofer GP, Johnson GA. Imaging inflammation: direct visualization of perivascular cuffing in EAE by magnetic resonance microscopy. J Magn Reson Imaging 2002;16:28-36. (Pubitemid 34700839)
15. Zivadinov R, Poloni GU, Marr K, et al. Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol 2011;11:128.
16. Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327-337. (Pubitemid 34127435)
17. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008;64:255-265.
18. Tedeschi G, Lavorgna L, Russo P, et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 2005;65:280-285. (Pubitemid 41022375)
19. Hochmeister S, Grundtner R, Bauer J, et al. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 2006;65:855-865. (Pubitemid 44371231)
20. Lassmann H. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am 2008;18:563-576, ix.
21. Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 2007;13:884-894. (Pubitemid 351540860)
22. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cere-brospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:392-399.
23. Zamboni P, Galeotti R. The chronic cerebrospinal venous insufficiency syndrome. Phlebology 2010;25:269-279.
24. Filippi M, Rocca MA, Barkhof F, et al. Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuro-imaging perspective. AJNR Am J Neuroradiol 2011;32: 424-427.
25. Greaney JL, Farquhar WB. Why do veins stiffen with advancing age? J Appl Physiol 2011;110:11-12.
26. Hainsworth R. Vascular capacitance: its control and importance. Rev Physiol Biochem Pharmacol 1986;105:101-173.
27. Flachenecker P. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. J Neurol 2007;254(suppl 2): II96-II101.
28. Ge Y, Law M, Johnson G, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 2005;26:1539-1547. (Pubitemid 43733458)
29. Wuerfel J, Paul F, Zipp F. Cerebral blood perfusion changes in multiple sclerosis. J Neurol Sci 2007;259:16-20. (Pubitemid 47031197)
30. De Keyser J, Steen C, Mostert JP, Koch MW. Hypoper-fusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab 2008;28:1645-1651.
31. Rosso C, Belleville M, Pires C, et al. Clinical usefulness of the visibility of the transcerebral veins at 3T on T2&z.ast;-weighted sequence in acute stroke patients. Eur J Radiol 2012;81: 1282-1287.
32. Bright MG, Donahue MJ, Duyn JH, Jezzard P, Bulte DP. The effect of basal vasodilation on hypercapnic and hypocapnic reactivity measured using magnetic resonance imaging. J Cereb Blood Flow Metab 2011;31:426-438.